****Senate probe into MFN pharma pricing deals & Trump tariffs** [developing]** [developing]
Key Questions
What is the overall impact of tariffs on Pfizer?
Minimal real impact due to shields till 2029, exemptions, and onshore shifts; positive FCF tailwind offsets LOE risks.
Trump EO 100% tariffs on branded imports (20% ramp to 100%/natsec) dodged via '25 MFN/HHS deals/shield till '29 (PFE/J&J US plants, prior exemptions thru '29 via 85% price cuts/MFN/TrumpRx w/43 PFE drugs/ABBV Humira 86% disc to $950/+100B pledge, biologics/rare dz exemptions, $400B+ US invests, low ~$12B exposure/smaller biotechs hit harder); TrumpRx.gov launch w/PFE 43 drugs; Senate Democrats requested MFN docs (PFE resp ~2026-03-23). Positive FCF tailwind vs LOEs; minimal impact. Monitor negotiations/AGM 4/23 exec comp.
Sources (12)
Updated Apr 8, 2026